- Dubai Stock Selloff May Bring Buying Opportunity
- Dubai Fallout Is a Correction, Not Another Crisis: El-Erian
- Dubai's Debt Woes Signal New Era for Creditors
- Longer Lines, Fuller Carts This Black Friday
- The World's Biggest Debtor Nations
- Five Tips for Buying a Foreclosed Home
- Shoppers Hit Black Friday Sales; Budgets Pared
- Slideshow: Fantasy Christmas Gifts 2009
- EA Sports Hopes to Pump Up Sales With Pop-Ups
- Longer Lines, Fuller Carts This Black Friday
- Dubai Stock Market Fear Has 'Legs': Dennis Gartman
- Obama's Emission Reduction Pledge Paints Future for Autos
- Is Super Bowl Halftime Act Too Old?
- Surprising Options Trades in TiVo Shares
- EA Sports Hopes to Pump Up Sales Through Pop-Up Locations
- 8 Retailers that Gain During the Holidays
- Farrell: What's Different On This Black Friday
- 10 Dividend Picks For Your Portfolio: Chief Investors
MOST SHARED
- 8 Retailers that Gain During the Holidays
- Get Paid Six Figures to Wear a T-Shirt?
- Finding the Holiday's Best Buys
- Dubai Spooks Investors But May Bring Buying Opportunity
- Dubai Fallout Is a Correction, Not Another Crisis: El-Erian
- Banks Play Down Dubai Exposure, Investors Still Wary
- Longer Lines, Fuller Carts This Black Friday
- Some of Dubai World's Major Holdings Around Globe
Text Size 
A first-of-its-kind study suggests that allergic reactions to the popular vaccine for cervical cancer are rare and can often be overcome.
Australian researchers report in the new issue of the "British Medical Journal" that hypersensitivity to the shots is uncommon and that most girls who do have a reaction can later go on to get the shots with no serious side effects. The doctors recommend that more studies be done, however.
Last year Australia started requiring adolescent schoolgirls to get the vaccine for the human papillomavirus (HPV), the sexually transmitted infection that is the leading cause of cervical cancer. After more than 380,000 doses were administered, 35 girls were identified as having had some kind of reaction. The problems included rash, hives and in two patients a more severe, widespread allergic response.
The BMJ study is being published close on the heels of a recent report out of the U.S. Centers for Disease Control that concluded there's no evidence that Gardasil has serious side effects.
Merck [MRK
Loading...
()
] sells the vaccine, Gardasil, in the United States. GlaxoSmithKline [GSK
Loading...
()
] is awaiting FDA approval on a similar product called Cervarix. The Australian researchers say the Merck shots may have ingredients that could be causing the small number of allergic reactions and that the GSK vaccine, which is made differently, could be an alternative for some girls.
Print
Email
- Bill Griffeth is taking a leave of absence from CNBC and Power Lunch for a year. Here's a message from Bill.
- Zhu Zhu Pets are this year's must-have toy, fetching $40 or more on eBay.
- From the why-didn’t-I-think-of-that file, we present Jason Sadler, a man whose job is wearing T-shirts.
- It may be the most unusual guide to business you'll read.
- "The Who" will be the halftime act for Super Bowl XLIV on Feb. 7 in Miami. Is the NFL behind the times?
- Some of the nation's top bartenders offer suggestions on what to serve at holiday celebrations this year.
Data is a real-time snapshot *Data is delayed at least 15 minutes